Abiopharma

🔍 Jorstad Chip S. (Executive)

Company: FIRST BUSEY CORP /NV/ (BUSE)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 429 shares of Common Stock at $20.315 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 64,543.75 | transaction_form_type: 5 | Footnotes: F1
• Acquired 238 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 64,781.75 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Shares were acquired under the First Busey Corporation Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
• F2: Represents dividend equivalent rights accrued on Restricted Stock Units in connection with the payment of a cash dividend on First Busey Corporation Common Stock. Each dividend equivalent right is the economic equivalent of one share of First Busey Corporation Common Stock.